Published • loading... • Updated
Over 25% of Ocular Complications From Dupilumab in Kids Developed After a Year
Summary by MedPage Today
2 Articles
2 Articles


Over 25% of Ocular Complications From Dupilumab in Kids Developed After a Year
(MedPage Today) -- ORLANDO -- Among children taking the monoclonal antibody dupilumab (Dupixent) for atopic dermatitis, more than a quarter of ocular complications developed after a year, according to a retrospective cohort study. Of the children...
·New York, United States
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium